{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T11:57:31Z","timestamp":1762862251469,"version":"build-2065373602"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,11]]},"DOI":"10.7759\/cureus.96555","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T11:53:16Z","timestamp":1762861996000},"source":"Crossref","is-referenced-by-count":0,"title":["Refractory Chronic Plaque Psoriasis and Psoriatic Arthritis Successfully Managed With Combined Secukinumab and Apremilast Therapy: A Case Report"],"prefix":"10.7759","author":[{"given":"Reem","family":"AlQusaimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawziah","family":"AlRujaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad","family":"AlSharhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa","family":"AlAwadhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suad","family":"Alassaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemah","family":"Abdulrahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v105.42945","article-title":"Epidemiology of psoriasis: a worldwide global study","volume":"105","author":"Skayem C","year":"2025","unstructured":"Skayem C, Taieb C, Halioua B, Baissac C, Saint Aroman M. Epidemiology of psoriasis: a worldwide global study. Acta Derm Venereol. 2025, 105:adv42945. 10.2340\/actadv.v105.42945","journal-title":"Acta Derm Venereol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1518681","article-title":"Dynamic trend analysis of global psoriasis burden from 1990 to 2021: a study of gender, age, and regional differences based on GBD 2021 data","volume":"13","author":"Xiong J","year":"2025","unstructured":"Xiong J, Xue T, Tong M, Xu L, Bai B. Dynamic trend analysis of global psoriasis burden from 1990 to 2021: a study of gender, age, and regional differences based on GBD 2021 data. Front Public Health. 2025, 13:1518681. 10.3389\/fpubh.2025.1518681","journal-title":"Front Public Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103202","article-title":"Global and regional epidemiology of psoriatic arthritis in patients with psoriasis: a comprehensive systematic analysis and modelling study","volume":"145","author":"Kang Z","year":"2024","unstructured":"Kang Z, Zhang X, Du Y, Dai SM. Global and regional epidemiology of psoriatic arthritis in patients with psoriasis: a comprehensive systematic analysis and modelling study. J Autoimmun. 2024, 145:103202. 10.1016\/j.jaut.2024.103202","journal-title":"J Autoimmun"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00483-2","article-title":"Interleukin-17 and interleukin-23: a narrative review of mechanisms of action in psoriasis and associated comorbidities","volume":"11","author":"Menter A","year":"2021","unstructured":"Menter A, Krueger GG, Paek SY, Kivelevitch D, Adamopoulos IE, Langley RG. Interleukin-17 and interleukin-23: a narrative review of mechanisms of action in psoriasis and associated comorbidities. Dermatol Ther (Heidelb). 2021, 11:385-400. 10.1007\/s13555-021-00483-2","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2018.17188","article-title":"Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: a novel approach","volume":"6","author":"Nisar MK","year":"2019","unstructured":"Nisar MK. Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: a novel approach. Eur J Rheumatol. 2019, 6:57-8. 10.5152\/eurjrheum.2018.17188","journal-title":"Eur J Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29536","article-title":"Types of psoriasis and their effects on the immune system","volume":"14","author":"Dhabale A","year":"2022","unstructured":"Dhabale A, Nagpure S. Types of psoriasis and their effects on the immune system. Cureus. 2022, 14:e29536. 10.7759\/cureus.29536","journal-title":"Cureus"},{"key":"ref7","article-title":"A short summary of clinical types of psoriasis","volume":"3","author":"Koca TT","year":"2016","unstructured":"Koca TT. A short summary of clinical types of psoriasis. North Clin Istanb. 2016, 3:79-82.","journal-title":"North Clin Istanb"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: a brief overview","volume":"21","author":"Raharja A","year":"2021","unstructured":"Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med (Lond). 2021, 21:170-3. 10.7861\/clinmed.2021-0257","journal-title":"Clin Med (Lond)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2007.08.003","article-title":"The clinical spectrum of psoriasis","volume":"25","author":"Naldi L","year":"2007","unstructured":"Naldi L, Gambini D. The clinical spectrum of psoriasis. Clin Dermatol. 2007, 25:510-8. 10.1016\/j.clindermatol.2007.08.003","journal-title":"Clin Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-007-0075-1","article-title":"Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines","volume":"9","author":"Fitch E","year":"2007","unstructured":"Fitch E, Harper E, Skorcheva I, Kurtz SE, Blauvelt A. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep. 2007, 9:461-7. 10.1007\/s11926-007-0075-1","journal-title":"Curr Rheumatol Rep"},{"key":"ref11","article-title":"Psoriasis as a systemic disease","volume":"121","author":"Mrowietz U","year":"2024","unstructured":"Mrowietz U, Lauffer F, Sondermann W, Gerdes S, Sewerin P. Psoriasis as a systemic disease. Dtsch Arztebl Int. 2024, 121:467-72.","journal-title":"Dtsch Arztebl Int"},{"key":"ref12","article-title":"Psoriasis: overview and diagnosis","author":"Kimmel GW","year":"2018","unstructured":"Kimmel GW, Lebwohl M. Psoriasis: overview and diagnosis. Evidence-Based Psoriasis. Updates in Clinical Dermatology. Bhutani T, Liao W, Nakamura M (ed): Springer, Cham, Switzerland; 2018."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.47162\/RJME.62.4.02","article-title":"Novel concepts in psoriasis: histopathology and markers related to modern treatment approaches","volume":"62","author":"Mihu C","year":"2021","unstructured":"Mihu C, Neag MA, Boc\u015fan IC, et al.. Novel concepts in psoriasis: histopathology and markers related to modern treatment approaches. Rom J Morphol Embryol. 2021, 62:897-906. 10.47162\/RJME.62.4.02","journal-title":"Rom J Morphol Embryol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-012-8305-3","article-title":"Clinical and histologic diagnostic guidelines for psoriasis: a critical review","volume":"44","author":"Johnson MA","year":"2013","unstructured":"Johnson MA, Armstrong AW. Clinical and histologic diagnostic guidelines for psoriasis: a critical review. Clin Rev Allergy Immunol. 2013, 44:166-72. 10.1007\/s12016-012-8305-3","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7957","article-title":"Imaging techniques in the diagnosis and monitoring of psoriasis","volume":"18","author":"Grajdeanu IA","year":"2019","unstructured":"Grajdeanu IA, Statescu L, Vata D, et al.. Imaging techniques in the diagnosis and monitoring of psoriasis. Exp Ther Med. 2019, 18:4974-80. 10.3892\/etm.2019.7957","journal-title":"Exp Ther Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17128","article-title":"Definition of psoriasis severity in routine clinical care: current guidelines fail to capture the complexity of long-term psoriasis management","volume":"179","author":"Augustin M","year":"2018","unstructured":"Augustin M, Langenbruch A, Gutknecht M, et al.. Definition of psoriasis severity in routine clinical care: current guidelines fail to capture the complexity of long-term psoriasis management. Br J Dermatol. 2018, 179:1385-91. 10.1111\/bjd.17128","journal-title":"Br J Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_548_18","article-title":"Apremilast coadministered with secukinumab for safe and effective control of psoriasis with resultant reduction of maintenance dose of the biologic","volume":"64","author":"De A","year":"2019","unstructured":"De A, Das S, Dhoot D, Sarda A. Apremilast coadministered with secukinumab for safe and effective control of psoriasis with resultant reduction of maintenance dose of the biologic. Indian J Dermatol. 2019, 64:239-41. 10.4103\/ijd.IJD_548_18","journal-title":"Indian J Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.696597","article-title":"Systematic review and recommendations to combine newer therapies with conventional therapy in psoriatic disease","volume":"8","author":"Arora S","year":"2021","unstructured":"Arora S, Das P, Arora G. Systematic review and recommendations to combine newer therapies with conventional therapy in psoriatic disease. Front Med (Lausanne). 2021, 8:696597. 10.3389\/fmed.2021.696597","journal-title":"Front Med (Lausanne)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2024.04.001","article-title":"Psoriasis in 2024 and beyond","volume":"42","author":"Cohen JM","year":"2024","unstructured":"Cohen JM. Psoriasis in 2024 and beyond. Dermatol Clin. 2024, 42:xv-xvi. 10.1016\/j.det.2024.04.001","journal-title":"Dermatol Clin"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/434728-refractory-chronic-plaque-psoriasis-and-psoriatic-arthritis-successfully-managed-with-combined-secukinumab-and-apremilast-therapy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T11:53:16Z","timestamp":1762861996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/434728-refractory-chronic-plaque-psoriasis-and-psoriatic-arthritis-successfully-managed-with-combined-secukinumab-and-apremilast-therapy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.96555","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,11]]}}}